Evidence map›Paper›PMID 35018502›Full record

ArticleCardiovascular and interventional radiology2022

Percutaneous Transsplenic Balloon-Assisted Transjugular Intrahepatic Portosystemic Shunt Placement in Patients with Portal Vein Obliteration for Portal Vein Recanalization: Feasibility, Safety and Effectiveness.

T C Meine, L S Becker, C L A Dewald, S K Maschke, B Maasoumy, E Jaeckel, H Wedemeyer, F K Wacker, B C Meyer, J B Hinrichs

Open access · hybridAbstract read
In one paragraph

Article in Cardiovascular and interventional radiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Expandable Constrained Transjugular Intrahepatic Portosystemic Shunt: An Individualised Approach for High-Risk Patients?Liver international : official journal of the International Association for the Study of the Liver · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

T C MeineInstitute for Diagnostic and Interventional Radiology, Hannover Medical School, OE8220 Carl-Neuberg-Straße 1, 30625, Hannover, Germany.
L S BeckerInstitute for Diagnostic and Interventional Radiology, Hannover Medical School, OE8220 Carl-Neuberg-Straße 1, 30625, Hannover, Germany.
C L A DewaldInstitute for Diagnostic and Interventional Radiology, Hannover Medical School, OE8220 Carl-Neuberg-Straße 1, 30625, Hannover, Germany.
S K MaschkeInstitute for Diagnostic and Interventional Radiology, Hannover Medical School, OE8220 Carl-Neuberg-Straße 1, 30625, Hannover, Germany.
B MaasoumyDepartment of Hepatology, Gastroenterology and Endocrinology, Hannover Medical School, Carl-Neuberg-Straße 1, 30625, Hannover, Germany.
E JaeckelDepartment of Hepatology, Gastroenterology and Endocrinology, Hannover Medical School, Carl-Neuberg-Straße 1, 30625, Hannover, Germany.
H WedemeyerDepartment of Hepatology, Gastroenterology and Endocrinology, Hannover Medical School, Carl-Neuberg-Straße 1, 30625, Hannover, Germany.
F K WackerInstitute for Diagnostic and Interventional Radiology, Hannover Medical School, OE8220 Carl-Neuberg-Straße 1, 30625, Hannover, Germany.
B C MeyerInstitute for Diagnostic and Interventional Radiology, Hannover Medical School, OE8220 Carl-Neuberg-Straße 1, 30625, Hannover, Germany.
J B HinrichsInstitute for Diagnostic and Interventional Radiology, Hannover Medical School, OE8220 Carl-Neuberg-Straße 1, 30625, Hannover, Germany. Hinrichs.jan@mh-hannover.de.ORCID http://orcid.org/0000-0002-0135-7082
Medizinische Hochschule Hannover · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo assess the feasibility, safety and effectiveness of portal vein recanalization (PVR)-transjugular portosystemic shunt (TIPS) placement via splenic access using a balloon puncture technique. MATERIALS AND

methodsIn a single-center retrospective study from March 2017 to February 2021, 14 consecutive patients with portal hypertension, chronic liver disease and portal vein occlusion or near-complete (> 95%) occlusion were referred for PVR-TIPS placement. Feasibility, safety and effectiveness including procedural characteristics such as technical success, complication profile and splenic access time (SAT), balloon positioning time (BPT), conventional portal vein entry time (CPVET), overall procedure time (OPT), fluoroscopy time (FT), dose-area product (DAP) and air kerma (AK) were evaluated.

resultsTranssplenic PVR-TIPS using balloon puncture technique was technically feasible in 12 of 14 patients (8 men, 49 ± 13 years). In two patients without detectable intrahepatic portal vein branches, TIPS placement was not feasible and both patients were referred for further treatment with nonselective beta blockers and endoscopic variceal ligation. No complications grade > 3 of the Cardiovascular and Interventional Radiological Society of Europe classification system occurred. The SAT was 25 ± 21 min, CPVET was 33 ± 26 min, the OPT was 158 ± 54 min, the FT was 42 ± 22 min, the DAP was 167.84 ± 129.23 Gy*cm

conclusionsTranssplenic PVR-TIPS using a balloon puncture technique is feasible and appears to be safe in our series of patients with obliteration of the portal vein. It expands the interventional options in patients with chronic PVT.

Indexed as

Hypertension, PortalPortasystemic Shunt, Transjugular IntrahepaticFeasibility StudiesFemaleHumansMalePortal VeinRetrospective StudiesTreatment OutcomeBalloon puncture techniquePortal vein obliterationPortal vein recanalization–Transjugular intrahepatic portosystemic shuntPortal vein thrombosisSplenic accessTranssplenic

Identifiers

PMID35018502
PMCPMC9018628
OpenAlexW4205206619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.